Form4insider filings, from the source

SEC Form 4 · accession 0001415889-15-002831

GYRE THERAPEUTICS, INC. · GYRE

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Period of report
Aug 20, 2015
Accepted (ET)
Aug 21, 2015 · 9:17 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001124105

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common Stock, $0.001 par valueF1,F2holding———425,417ISee Explanation of Reponses
Common Stock, $0.001 par valueF1,F3holding———244,843ISee Explanation of Reponses
Common Stock, $0.001 par valueF1,F4holding———161,480ISee Explanation of Reponses
Common Stock, $0.001 par valueF1,F5,F6holding———49,926ISee Explanation of Reponses

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses